XML 40 R33.htm IDEA: XBRL DOCUMENT
v3.26.1

NET LOSS PER SHARE (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2026
Earnings Per Share [Abstract] |
Schedule of Basic and Diluted Net Loss Per Share | The following table presents the calculation of basic and diluted net loss per share for the Company’s common stock:
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2026 |  |  | 2025 |  |  | 2026 |  |  | 2025 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net Loss |  | $ | (9,298 | ) |  | $ | (9,225 | ) |  | $ | (17,921 | ) |  | $ | (18,643 | )
Numerator for Basic and Dilutive EPS – Loss available to common stockholders |  | $ | (9,298 | ) |  | $ | (9,225 | ) |  | $ | (17,921 | ) |  | $ | (18,643 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |
Common Stock |  |  | 99,797,156 |  |  |  | 78,077,118 |  |  |  | 98,751,951 |  |  |  | 76,893,733 |
Denominator for Basic and Dilutive EPS - Weighted-average common stock |  |  | 99,797,156 |  |  |  | 78,077,118 |  |  |  | 98,751,951 |  |  |  | 76,893,733 |
Basic and dilutive net loss per share |  | $ | (0.09 | ) |  | $ | (0.12 | ) |  | $ | (0.18 | ) |  | $ | (0.24 | )
Schedule of Anti-dilutive Common Equivalent Shares | Anti-dilutive common equivalent shares were as follows:
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2026 |  |  | 2025 |  |  | 2026 |  |  | 2025 |
Outstanding options to purchase common stock |  |  | 15,688,709 |  |  |  | 17,016,565 |  |  |  | 15,688,709 |  |  |  | 17,016,565 |
Outstanding RSUs |  |  | 5,921,884 |  |  |  | 2,567,691 |  |  |  | 5,921,884 |  |  |  | 2,567,691 |
Warrants issued in connection with February 2025 Offering |  |  | 4,257,419 |  |  |  | 4,511,178 |  |  |  | 4,257,419 |  |  |  | 4,511,178 |
Warrants issued in connection with Loan Agreement |  |  | 562,500 |  |  |  | — |  |  |  | 562,500 |  |  |  | — |
Total anti-dilutive common equivalent shares |  |  | 26,430,512 |  |  |  | 24,095,434 |  |  |  | 26,430,512 |  |  |  | 24,095,434 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration